Dr. Travis Rush
Dr. Travis Rush received his B.S. in physiological sciences and went on to earn his Ph.D. in neuroscience from Marquette University in Milwaukee, WI, where he studied the mechanisms of action for several classes of environmental neurotoxicants, and how they relate to those involved in neurodegenerative diseases, such as Alzheimer’s disease and ALS. Upon completing his doctorate, he joined the lab of Dr. Alain Buisson at the Grenoble Institute of Neurosciences in Grenoble, France, to study the mechanisms of neuronal dysfunction involved in the onset of Alzheimer’s disease using biochemistry and live-neuron imaging in vitro. After his first postdoctoral appointment was complete in the Spring of 2014, he returned to the U.S. to join Dr. Erik Roberson’s team at UAB. Here, he continues his study of Alzheimer’s disease in vitro and using in vivo mouse models. In collaboration with Southern Research, and through the Alabama Drug Discovery Alliance, he is driving the development of compounds aimed at a promising therapeutic target previously identified in the Roberson lab.